The performance of uniportal VATS lobectomy (uVATS) for non‐small cell lung cancer (NSCLC) larger than 5 cm is uncertain due to a lack of evidence. Here, we present a retrospective,… Click to show full abstract
The performance of uniportal VATS lobectomy (uVATS) for non‐small cell lung cancer (NSCLC) larger than 5 cm is uncertain due to a lack of evidence. Here, we present a retrospective, propensity‐score matched cohort study to evaluate the safety and effectiveness of uVATS for patients with locally advanced NSCLC.
               
Click one of the above tabs to view related content.